Apoptosis in the central nervous system: Mechanisms and protective strategies

被引:0
|
作者
Kajta, M [1 ]
机构
[1] Polish Acad Sci, Inst Pharmacol, Dept Expt Neuroendocrinol, PL-31343 Krakow, Poland
来源
POLISH JOURNAL OF PHARMACOLOGY | 2004年 / 56卷 / 06期
关键词
caspases; calpains; JNKs; GSK-3; beta; neural development; neurodegeneration; estrogens;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Naturally occurring neuronal cell death, which is essential for normal development, tissue homeostasis and as a defence against pathogens, is generally considered to be apoptotic. Apoptosis, called also a programmed cell death, though the meanings of these terms are not identical, is a common phenomenon induced either by specific insults mediated through so-called "death receptors" (external pathway) or by non-specific insults leading to reduction of mitochondrial potential (internal pathway). At the molecular level, apoptosis is regulated by the activation of the caspase cascade, which depends either upon the participation of mitochondria and the activation of procaspase-9 or on the interaction of a death receptor with its ligand and subsequent activation of procaspase-8. Considering various mechanisms of programmed cell death, either during neural development or neurodegeneration, finding the most suitable and effective protective strategy needs evaluation of risk-to-benefit ratio. Unlike malignant tissues, neuronal cells have to be protected, but only if the protection does not disturb natural cell elimination. Defining molecular mechanisms is, therefore, the necessary step preceding the adaptation of new protective and then, possibly, therapeutic strategies. At present, the most promising are discoveries related to caspases, JNK, and GSK-3beta and their crucial role in stress-dependent and spontaneous apoptosis. Inhibitors of caspases and JNKs succeed in defending cells against kainate-, beta-amyloid- or MPTP-induced neuronal cell death. Among protective agents those, which easily cross the blood-brain barrier and exert profound neuroprotective action without side effects, seem to be the most important.
引用
收藏
页码:689 / 700
页数:12
相关论文
共 50 条
  • [1] Mechanisms of apoptosis as drug targets in the central nervous system
    Spence, P
    Franco, R
    Wood, A
    Moyer, JA
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 1996, 6 (04) : 345 - 366
  • [2] Mechanisms of apoptosis in central nervous system tumors: application to theory.
    Steinbach J.P.
    Weller M.
    [J]. Current Neurology and Neuroscience Reports, 2002, 2 (3) : 246 - 253
  • [3] Radiation Toxicity in the Central Nervous System: Mechanisms and Strategies for Injury Reduction
    Smart, DeeDee
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2017, 27 (04) : 332 - 339
  • [4] Apoptosis and pathologies of the central nervous system
    Martin, S
    Vallette, FM
    [J]. NEUROCHIRURGIE, 2000, 46 (04) : 370 - 375
  • [5] Apoptosis in tumors of the central nervous system
    Imitola, J
    Nikas, DC
    Black, PM
    [J]. CRITICAL REVIEWS IN NEUROSURGERY, 1997, 7 (06) : 391 - 399
  • [6] Neurorestoratologic Strategies and Mechanisms in the Nervous System
    Chen, Lin
    Ao, Qiang
    Sharma, Hari Shanker
    Wang, Aijun
    Feng, Shiqing
    [J]. BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [7] Protective effects and mechanisms of sirtuins in the nervous system
    Zhang, Feng
    Wang, Suping
    Gan, Li
    Vosler, Peter S.
    Gao, Yanqin
    Zigmond, Michael J.
    Chen, Jun
    [J]. PROGRESS IN NEUROBIOLOGY, 2011, 95 (03) : 373 - 395
  • [8] CENTRAL NERVOUS SYSTEM - MOTOR MECHANISMS
    ELDRED, E
    BUCHWALD, J
    [J]. ANNUAL REVIEW OF PHYSIOLOGY, 1967, 29 : 573 - +
  • [9] CENTRAL NERVOUS SYSTEM - AFFERENT MECHANISMS
    RODIECK, RW
    [J]. ANNUAL REVIEW OF PHYSIOLOGY, 1971, 33 : 203 - +
  • [10] Mechanisms of hypertension in the central nervous system
    Kubo, Takao
    [J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2006, 126 (09): : 695 - 709